IFNAR1 and early-onset autosomal dominant Alzheimer disease: Although our in vitro findings from human immortalized brain endothelial cells do not truly resemble the in vivo context of brain endothelial cells in the brain of AD patients, our results suggest that specific targeting of IFNAR1 may be a potential therapeutic avenue to reduce brain endothelial permeability in Alzheimer’s disease.